Maricann Expanding into German Medical Cannabis Market
The original release is unavailable here.
Earlier from Wayland
- Maricann Group Celebrates Completion of RTO and First Day of Trading
- Early Warning Report Issued Pursuant to National Instrument 62‐103 Acquisition of Shares of Maricann Group Inc.
- MARICANN GROUP INC. (formerly, DANBEL VENTURES INC.) AND MARICANN INC. ANNOUNCE CLOSING OF REVERSE TAKEOVER TRANSACTION AND LISTING ON THE CANADIAN SECURITIES EXCHANGE
- Danbel ventures inc. announces shareholder approval of all matters at its annual and special meeting
- Danbel ventures inc. announces update in respect of the reverse takeover with maricann inc.
Later from Wayland
- Maricann secures $42,500,000 non-dilutive financing for further german expansion
- Maricann Group, Inc. Gains Exposure to TSX with Listing on Horizons Marijuana Life Sciences Index ETF
- Maricann Group Enters Into Letter of Intent with McKesson Canada Retail Banner Group
- Maricann Group Inc. Announces Appointment of New Director
- OTC Markets Group Welcomes New OTCQB Companies – September 15
Follow Wayland into a list and get an email when it puts out news.
Follow Wayland